WAYNE, Pa., Sept. 5, 2013 /PRNewswire/ -- Ryan & Maniskas, LLP is investigating potential claims against the board of directors of Rochester Medical Corporation ("Rochester Medical" or the "Company") (NASDAQ: ROCM) concerning possible breaches of fiduciary duty and other violations of law related to the Company's efforts to sell the Company to C.R. Bard, Inc. in a transaction valued at approximately $262 million.
Under the terms of the agreement, shareholders of Rochester Medical will receive $20.00 per share in cash for each share of Rochester Medical they own.
If you own shares of Rochester Medical and would like to learn more about these claims or if you wish to discuss these matters and have any questions concerning this announcement or your rights, contact Richard A. Maniskas, Esquire toll-free at (877) 316-3218 or to sign up online, visit: www.rmclasslaw.com/cases/rocm. You may also email Mr. Maniskas at firstname.lastname@example.org.Our investigation concerns possible breaches of fiduciary duty and other violations of state law by Rochester Medical's Board of Directors for not acting in the Company's shareholders' best interests in connection with the sale process. Ryan & Maniskas, LLP is a national shareholder litigation firm. Ryan & Maniskas, LLP is devoted to protecting the interests of individual and institutional investors in shareholder actions in state and federal courts nationwide. To learn more about the class action process, please visit: www.rmclasslaw.com. CONTACT: Ryan & Maniskas, LLP Richard A. Maniskas, Esquire 995 Old Eagle School Rd., Suite 311 Wayne, PA 19087 877-316-3218 www.rmclasslaw.com/cases/rocm email@example.com SOURCE Ryan & Maniskas, LLP